FDA NEEDS MORE DATA TO MAKE PRILOSEC AN OTC DRUG

WASHINGTON -- Prilosec, a prescription heartburn remedy, has reached an important goal in making the possible switch from prescription to over-the-counter use.A joint Food and Drug Administration advisory panel here on Oct. 20 confirmed the safety and efficacy of Prilosec for over-the-counter use, according to Jim Coyne, senior manager of gastro-intestinal public affairs for AstraZeneca, the drug's

WASHINGTON -- Prilosec, a prescription heartburn remedy, has reached an important goal in making the possible switch from prescription to over-the-counter use.

A joint Food and Drug Administration advisory panel here on Oct. 20 confirmed the safety and efficacy of Prilosec for over-the-counter use, according to Jim Coyne, senior manager of gastro-intestinal public affairs for AstraZeneca, the drug's manufacturer based in Wilmington, Del. However, he stressed the FDA needs more data be

Register to view the full article